60 Degrees Pharmaceuticals, Inc. (SXTP) quarterly income statement — complete revenue, gross profit & net income history
| Sales/Revenue | 162.09K | 303.38K | 437.6K | 100.93K | 163.55K | 261.44K | 135.29K | 124.97K | 105.67K | 42.71K | 51.19K | 59.53K |
| Revenue Growth % | -0.89% | 16.04% | 223.45% | -19.24% | 54.77% | 512.17% | 164.31% | 109.92% | 515.39% | 156.45% | -69.56% | - |
| Cost of Goods Sold | 85.72K | 120.68K | 537.69K | 50.05K | 73.27K | 118.08K | 111.69K | 89.56K | 65.44K | 146.26K | 71.2K | 183.98K |
| COGS % of Revenue | 52.88% | 39.78% | 122.87% | 49.59% | 44.8% | 45.16% | 82.55% | 71.67% | 61.92% | 342.47% | 139.09% | 309.04% |
| Gross Profit | 76.38K | 182.7K | -100.09K | 50.88K | 90.28K | 143.36K | 23.61K | 35.41K | 40.24K | -103.55K | -20.01K | -124.44K |
| Gross Margin % | 47.12% | 60.22% | -22.87% | 50.41% | 55.2% | 54.84% | 17.45% | 28.33% | 38.08% | -242.47% | -39.09% | -209.04% |
| Gross Profit Growth % | -15.4% | 27.44% | -523.99% | 43.7% | 124.37% | 238.45% | 217.98% | 128.45% | 171.92% | 48.23% | -126.36% | - |
| Operating Expenses | 2.17M | 2.1M | 2.23M | 1.66M | 2M | 2.22M | 2.14M | 4.22M | 1.38M | 1.79M | 1.5M | 663.55K |
| OpEx % of Revenue | 1339.57% | 692.21% | 508.55% | 1640.42% | 1223.56% | 848.83% | 1583.45% | 3380.08% | 1308.44% | 4192.78% | 2933.8% | 1114.61% |
| Selling, General & Admin | 1.89M | 1.47M | 1.51M | 1.61M | 1.69M | 1.61M | 1.22M | 1.13M | 1.08M | 1.69M | 1.31M | 462.8K |
| SG&A % of Revenue | 1165.93% | 485.91% | 344.29% | 1597.87% | 1031.03% | 614% | 898.09% | 903.85% | 1017.41% | 3958.16% | 2566.26% | 777.39% |
| Research & Development | 281.46K | 638.87K | 809.78K | 249.88K | 407.62K | 613.96K | 940.06K | 3.1M | 337.18K | 100.2K | 263.7K | 203.87K |
| R&D % of Revenue | 173.64% | 210.58% | 185.05% | 247.58% | 249.23% | 234.84% | 694.83% | 2476.82% | 319.08% | 234.62% | 515.17% | 342.46% |
| Other Operating Expenses | 0 | -12.99K | -90.96K | -206.94K | -92.73K | 0 | -12.82K | -728 | -29.63K | 0 | -75.57K | -3.12K |
| Operating Income | -2.09M | -1.92M | -2.33M | -1.6M | -1.91M | -2.08M | -2.12M | -4.19M | -1.34M | -1.89M | -1.52M | -788K |
| Operating Margin % | -1292.45% | -631.99% | -531.42% | -1590.01% | -1168.36% | -794% | -1566% | -3351.75% | -1270.37% | -4435.25% | -2972.89% | -1323.65% |
| Operating Income Growth % | -9.63% | 7.63% | -9.76% | 61.69% | -42.34% | -9.59% | -39.23% | -431.57% | -41.21% | -176.64% | -607.41% | - |
| EBITDA | -2.07M | -1.89M | -2.3M | -1.59M | -1.89M | -2.06M | -2.1M | -4.18M | -1.32M | -1.87M | -1.5M | -763K |
| EBITDA Margin % | -1276.49% | -624.22% | -526.21% | -1570.51% | -1158.09% | -787.9% | -1555.17% | -3342.94% | -1249.42% | -4380.35% | -2923.2% | -1281.67% |
| EBITDA Growth % | -9.24% | 8.06% | -9.44% | 62.06% | -43.46% | -10.11% | -40.61% | -447.54% | -42.87% | -182.04% | -664.68% | - |
| D&A (Non-Cash Add-back) | 25.86K | 23.57K | 22.83K | 19.68K | 16.8K | 15.95K | 14.66K | 11.01K | 22.13K | 23.44K | 25.43K | 24.99K |
| EBIT | -2.09M | -1.44M | -2.32M | -1.73M | -1.88M | -2.05M | -2.16M | -4.17M | 429.45K | -2.04M | 4.21M | -2.24M |
| Net Interest Income | -1.39K | -3.09K | -1.71K | -1.22K | -1.79K | -1.42K | -1.47K | -3.62K | -1.4K | -5.45K | -40.11K | -1.1M |
| Interest Income | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Interest Expense | 1.39K | 3.09K | 1.71K | 1.22K | 1.79K | 1.42K | 1.47K | 3.62K | 1.4K | 5.45K | 40.11K | 1.1M |
| Other Income/Expense | 4.81K | 476.48K | 8.74K | -128.6K | 33.64K | 26.41K | -41.56K | 14.96K | 1.77M | -151.99K | 5.7M | -2.56M |
| Pretax Income | -2.09M | -1.44M | -2.32M | -1.73M | -1.88M | -2.05M | -2.16M | -4.17M | 428.05K | -2.05M | 4.17M | -3.34M |
| Pretax Margin % | -1289.49% | -474.93% | -529.43% | -1717.42% | -1147.79% | -783.9% | -1596.72% | -3339.78% | 405.06% | -4791.15% | 8153.48% | -5616.35% |
| Income Tax | 0 | -1.81K | 250 | 1.5K | 63 | -501 | 250 | 438 | 63 | 61 | 63 | 63 |
| Effective Tax Rate % | 0% | 0.13% | -0.01% | -0.09% | -0% | 0.02% | -0.01% | -0.01% | 0.01% | -0% | 0% | -0% |
| Net Income | -2.09M | -1.44M | -2.32M | -1.73M | -1.88M | -2.05M | -2.16M | -4.17M | 430.47K | -1.96M | 4.18M | -3.34M |
| Net Margin % | -1289.49% | -474.98% | -529.48% | -1717.72% | -1147.37% | -783.65% | -1596.38% | -3338.95% | 407.36% | -4584.98% | 8172.22% | -5604.64% |
| Net Income Growth % | -11.38% | 29.66% | -7.28% | 58.45% | -535.93% | -4.63% | -151.63% | -25.06% | 116.56% | -16.9% | 389% | - |
| Net Income (Continuing) | -2.09M | -1.44M | -2.32M | -1.73M | -1.88M | -2.05M | -2.16M | -4.17M | 427.99K | -2.05M | 4.17M | -3.34M |
| Discontinued Operations | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Minority Interest | -84.7K | -83.76K | -83.26K | -82.55K | -81.35K | -80.59K | -76.71K | -75.99K | -74.52K | -72.04K | -38.1K | -576.83K |
| EPS (Diluted) | -1.28 | -1.35 | -2.52 | -5.00 | -6.24 | -18.00 | -3.52 | -16.44 | 7.32 | -1.36 | 2.88 | -2.32 |
| EPS Growth % | 79.49% | 92.5% | 28.41% | 69.59% | -185.25% | -1223.53% | -222.22% | -608.62% | 489.36% | 2.86% | 376.92% | - |
| EPS (Basic) | -1.28 | -1.35 | -2.52 | -5.00 | -6.24 | -18.00 | -3.52 | -16.92 | 7.32 | -1.36 | 2.88 | -2.32 |
| Diluted Shares Outstanding | 1.73M | 670.21K | 918.85K | 368.22K | 320.87K | 113.65K | 610.8K | 253.69K | 42.19K | 1.45M | 1.45M | 1.45M |
| Basic Shares Outstanding | 1.73M | 670.21K | 918.85K | 368.22K | 320.87K | 113.65K | 610.8K | 246.72K | 42.19K | 1.45M | 1.45M | 1.45M |
| Dividend Payout Ratio | - | - | - | - | - | - | - | - | - | - | - | - |